- Home
- MOLN vs OPFI Comparison
MOLN vs OPFI Comparison
Compare MOLN & OPFI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MOLN
- OPFI
- Stock Information
- Founded
- MOLN 2004
- OPFI 2009
- Country
- MOLN Switzerland
- OPFI United States
- Employees
- MOLN N/A
- OPFI N/A
- Industry
- MOLN
- OPFI Finance: Consumer Services
- Sector
- MOLN
- OPFI Finance
- Exchange
- MOLN Nasdaq
- OPFI Nasdaq
- Market Cap
- MOLN 192.4M
- OPFI 290.9M
- IPO Year
- MOLN 2021
- OPFI N/A
- Fundamental
- Price
- MOLN $4.89
- OPFI $15.35
- Analyst Decision
- MOLN
- OPFI Buy
- Analyst Count
- MOLN 0
- OPFI 2
- Target Price
- MOLN N/A
- OPFI $7.50
- AVG Volume (30 Days)
- MOLN 5.7K
- OPFI 2.5M
- Earning Date
- MOLN 03-13-2025
- OPFI 03-06-2025
- Dividend Yield
- MOLN N/A
- OPFI 0.80%
- EPS Growth
- MOLN N/A
- OPFI 775.86
- EPS
- MOLN N/A
- OPFI 0.38
- Revenue
- MOLN $7,105,397.00
- OPFI $260,661,000.00
- Revenue This Year
- MOLN N/A
- OPFI N/A
- Revenue Next Year
- MOLN $29.41
- OPFI $6.51
- P/E Ratio
- MOLN N/A
- OPFI $39.68
- Revenue Growth
- MOLN N/A
- OPFI 23.85
- 52 Week Low
- MOLN $3.32
- OPFI $2.35
- 52 Week High
- MOLN $12.70
- OPFI $15.13
- Technical
- Relative Strength Index (RSI)
- MOLN 41.97
- OPFI 76.48
- Support Level
- MOLN $5.22
- OPFI $11.21
- Resistance Level
- MOLN $5.35
- OPFI $14.85
- Average True Range (ATR)
- MOLN 0.12
- OPFI 1.17
- MACD
- MOLN -0.03
- OPFI 0.17
- Stochastic Oscillator
- MOLN 0.00
- OPFI 77.48
About MOLN Molecular Partners AG
Molecular Partners AG is a clinical stage biopharmaceutical company. The Company has programs in various stages of pre-clinical and clinical development, with oncology as its main focus. The firm develops protein therapeutics called DARPin therapeutics for the treatment of serious diseases, including cancer and sight-threatening disorders. The company's product pipeline is organized principally through three areas: Ophthalmology, including the creation of therapies for retinal diseases like wet age-related macular degeneration and diabetic macular edema; the Oncology pipeline comprises DARPin candidates with novel modes of action, including multi-DARPin compounds; and Immuno-oncology for anticancer treatment.
About OPFI OppFi Inc.
OppFi Inc is a tech-enabled, mission-driven specialty finance platform that broadens the reach of community banks to extend credit access to everyday Americans. It recognizes revenue through finance charges on installment and SalaryTap contracts based on the interest method.